» Articles » PMID: 24719334

The RNA-binding Protein TDP-43 Selectively Disrupts MicroRNA-1/206 Incorporation into the RNA-induced Silencing Complex

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2014 Apr 11
PMID 24719334
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA (miRNA) maturation is regulated by interaction of particular miRNA precursors with specific RNA-binding proteins. Following their biogenesis, mature miRNAs are incorporated into the RNA-induced silencing complex (RISC) where they interact with mRNAs to negatively regulate protein production. However, little is known about how mature miRNAs are regulated at the level of their activity. To address this, we screened for proteins differentially bound to the mature form of the miR-1 or miR-133 miRNA families. These muscle-enriched, co-transcribed miRNA pairs cooperate to suppress smooth muscle gene expression in the heart. However, they also have opposing roles, with the miR-1 family, composed of miR-1 and miR-206, promoting myogenic differentiation, whereas miR-133 maintains the progenitor state. Here, we describe a physical interaction between TDP-43, an RNA-binding protein that forms aggregates in the neuromuscular disease, amyotrophic lateral sclerosis, and the miR-1, but not miR-133, family. Deficiency of the TDP-43 Drosophila ortholog enhanced dmiR-1 activity in vivo. In mammalian cells, TDP-43 limited the activity of both miR-1 and miR-206, but not the miR-133 family, by disrupting their RISC association. Consistent with TDP-43 dampening miR-1/206 activity, protein levels of the miR-1/206 targets, IGF-1 and HDAC4, were elevated in TDP-43 transgenic mouse muscle. This occurred without corresponding Igf-1 or Hdac4 mRNA increases and despite higher miR-1 and miR-206 expression. Our findings reveal that TDP-43 negatively regulates the activity of the miR-1 family of miRNAs by limiting their bioavailability for RISC loading and suggest a processing-independent mechanism for differential regulation of miRNA activity.

Citing Articles

Epigenetics in the formation of pathological aggregates in amyotrophic lateral sclerosis.

Noches V, Campos-Melo D, Droppelmann C, Strong M Front Mol Neurosci. 2024; 17:1417961.

PMID: 39290830 PMC: 11405384. DOI: 10.3389/fnmol.2024.1417961.


Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications.

Koike Y, Onodera O Front Neurosci. 2023; 17:1131758.

PMID: 36895420 PMC: 9989161. DOI: 10.3389/fnins.2023.1131758.


The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.

Weng Y, Chang Y, Chern Y Int J Mol Sci. 2023; 24(4).

PMID: 36834853 PMC: 9959302. DOI: 10.3390/ijms24043443.


TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.

Lepine S, Castellanos-Montiel M, Durcan T Transl Neurodegener. 2022; 11(1):56.

PMID: 36575535 PMC: 9793560. DOI: 10.1186/s40035-022-00331-z.


MiR-206 improves intervertebral disk degeneration by targeting GJA1.

Zhou P, Xu P, Yu W, Li H J Orthop Surg Res. 2022; 17(1):157.

PMID: 35279164 PMC: 8917658. DOI: 10.1186/s13018-022-03044-1.


References
1.
Gagan J, Dey B, Dutta A . MicroRNAs regulate and provide robustness to the myogenic transcriptional network. Curr Opin Pharmacol. 2012; 12(3):383-8. PMC: 3369106. DOI: 10.1016/j.coph.2012.02.001. View

2.
Simon D, Madison J, Conery A, Thompson-Peer K, Soskis M, Ruvkun G . The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell. 2008; 133(5):903-15. PMC: 2553566. DOI: 10.1016/j.cell.2008.04.035. View

3.
Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo M . Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation. 2009; 120(23):2377-85. PMC: 2825656. DOI: 10.1161/CIRCULATIONAHA.109.879429. View

4.
Wystub K, Besser J, Bachmann A, Boettger T, Braun T . miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development. PLoS Genet. 2013; 9(9):e1003793. PMC: 3777988. DOI: 10.1371/journal.pgen.1003793. View

5.
Zhao Y, Samal E, Srivastava D . Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005; 436(7048):214-20. DOI: 10.1038/nature03817. View